Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-SC014724
Host Cell : HEK293 (CHO and other cell types are also available) Size : >1x106 frozen cells/vial
| Cat. No. | CSC-SC014724 |
| Description | Using Creative Biogene's proprietary lentiviral vectors, we subclone the target gene into lentivector, generate the lentivirus particles, sequentially infect the cell line HEK293 (other cell types are also available according to your requirements), and select the clones constantly expressing target gene at high level. |
| Target Gene | SMARCA4 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 (CHO and other cell types are also available) |
| Host Cell Species | Species varies |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | 2 × 10^6 cells / vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry Ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 [ Homo sapiens ] |
| Gene Symbol | SMARCA4 |
| Synonyms | BRG1; SNF2; SWI2; MRD16; RTPS2; BAF190; SNF2L4; SNF2LB; hSNF2b; BAF190A |
| GeneID | 6597 |
| Uni ProtID | A7E2E1 |
| mRNA Refseq | NM_001128844.1 |
| Protein Refseq | NP_001122316.1 |
| Chromosome Location | 19p13.2 |
| Function | ATP binding; DNA-dependent ATPase activity; RNA polymerase II regulatory region sequence-specific DNA binding; Tat protein binding; androgen receptor binding; chromatin binding; helicase activity; histone acetyl-lysine binding; p53 binding; protein N-terminus binding; protein binding; transcription coactivator activity; transcription coactivator activity; transcription corepressor activity; |
| Pathway | Direct p53 effectors, organism-specific biosystem; Glucocorticoid receptor regulatory network, organism-specific biosystem; Integrated Breast Cancer Pathway, organism-specific biosystem; Regulation of Wnt-mediated beta catenin signaling and target gene transcription, organism-specific biosystem; Regulation of retinoblastoma protein, organism-specific biosystem; TNF-alpha/NF-kB Signaling Pathway, organism-specific biosystem; |
| MIM | 603254 |
SWI/SNF-associated matrix-associated actin-dependent chromatin regulator subfamily a member 4 (SMARCA4, also known as BRG1), is the ATPase subunit of the SWI/SNF chromatin remodeling complex and plays an important regulatory role in many cytogenetic and cellular processes during cancer development. However, the biological function and mechanism of SMARCA4 in oral squamous cell carcinoma (OSCC) remain unclear. Here, researchers explored the role of SMARCA4 in OSCC and its potential mechanisms. Using tissue microarray technology, they found that SMARCA4 is highly expressed in OSCC tissues. Furthermore, high expression of SMARCA4 promotes the in vitro migration and invasion of OSCC cells, as well as tumor growth and invasion in vivo. These phenomena are associated with the promoting effect of epithelial-mesenchymal transition (EMT). Bioinformatics analysis and luciferase reporter gene assays confirmed that SMARCA4 is a target gene of microRNA miR-199a-5p. Further mechanistic studies showed that miR-199a-5p-regulated SMARCA4 can promote tumor cell invasion and metastasis through EMT. These findings indicate that the miR-199a-5p-SMARCA4 axis plays a role in tumorigenesis by promoting the invasion and metastasis of OSCC cells through the regulation of EMT. These results reveal the role and mechanism of SMARCA4 in OSCC, which may have significant implications for the treatment of OSCC.
Since tumor invasion and metastasis are closely associated with the progression of oral squamous cell carcinoma (OSCC), researchers investigated whether SMARCA4 is involved in the migration and invasion of OSCC cells. Scratch assays showed that SMARCA4 overexpression significantly enhanced the migration ability of SAS and CAL-27 cells (Figure 1A, B). Transwell migration assays showed that, compared with the corresponding NC group, SMARCA4-overexpressing SAS and CAL-27 cells exhibited significantly enhanced migration and invasion abilities (Figure 1C, D). Cancer cell invasion and eventual metastasis require epithelial cells to undergo a dedifferentiation process, namely epithelial-mesenchymal transition (EMT). The loss of E-cadherin and the upregulation of mesenchymal markers (such as vimentin) are considered key events in EMT. Immunofluorescence assays showed that E-cadherin expression was significantly attenuated in SMARCA4-overexpressing OSCC cells, while vimentin expression was upregulated (Figure 1E, F). Western blot analysis further confirmed these results (Figure 1G, H).
Figure 1. SMARCA4 promotes OSCC cell migration and invasion. (Xu, Mingyan, et al., 2023)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.